Becton Dickinson (BDX) Interest Expenses (2009 - 2026)
Becton Dickinson's (BDX) quarterly Interest Expenses came in at $132.0 million in Q2 2026, down 13.16% year-over-year from $152.0 million in Q2 2025, and down 11.41% quarter-over-quarter from $149.0 million in Q1 2026.
Analysis
Becton Dickinson (BDX) Interest Expenses (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Interest Expenses for 18 consecutive years, with $132.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Expenses fell 13.16% year-over-year to $132.0 million in Q2 2026; TTM through Jun 2026 was $589.0 million, a 3.76% decrease from a year earlier, with the FY2025 full-year figure at $613.0 million, up 16.1% from the prior year.
- Interest Expenses was $132.0 million for Q2 2026 at Becton Dickinson, down from $149.0 million in the prior quarter.
- Over five years, Interest Expenses peaked at $155.0 million in Q3 2024 and troughed at $97.0 million in Q1 2022.
- A 5-year average of $129.2 million and a median of $128.5 million in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses declined 21.77% in 2022 and jumped 39.64% in 2024, its largest moves.
- Over 5 years, Interest Expenses stood at $102.0 million in 2022, then advanced by 8.82% to $111.0 million in 2023, then surged by 39.64% to $155.0 million in 2024, then slipped by 1.29% to $153.0 million in 2025, then decreased by 13.73% to $132.0 million in 2026.
- The last three Interest Expenses figures came in at $132.0 million (Q2 2026), $149.0 million (Q1 2026), and $153.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 132.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 2.60 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | - |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 2.31 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 281,000.00 |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 18,705.00 |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 50,456.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132.00 Mn |
| Mar 31, 2026 | 149.00 Mn |
| Dec 31, 2025 | 153.00 Mn |
| Sep 30, 2025 | 155.00 Mn |
| Jun 30, 2025 | 152.00 Mn |
| Mar 31, 2025 | 150.00 Mn |
| Dec 31, 2024 | 155.00 Mn |
| Sep 30, 2024 | 155.00 Mn |
| Jun 30, 2024 | 137.00 Mn |
| Mar 31, 2024 | 125.00 Mn |
| Dec 31, 2023 | 111.00 Mn |
| Sep 30, 2023 | 113.00 Mn |
| Jun 30, 2023 | 119.00 Mn |
| Mar 31, 2023 | 118.00 Mn |
| Dec 31, 2022 | 102.00 Mn |
| Sep 30, 2022 | 104.00 Mn |
| Jun 30, 2022 | 99.00 Mn |
| Mar 31, 2022 | 97.00 Mn |
| Dec 31, 2021 | 98.00 Mn |
| Sep 30, 2021 | 111.00 Mn |